Cargando…
Intrauterine Reprogramming of the Polycystic Ovary Syndrome: Evidence from a Pilot Study of Cord Blood Global Methylation Analysis
Polycystic ovary syndrome (PCOS) affects 5–15% of women. PCOS is a heterogeneous disorder displaying endocrine, metabolic, and reproductive dysfunction and cardiovascular risk manifestations. Evidence of heritability exists, but only a portion of the genetic transmission has been identified by genom...
Autores principales: | Lambertini, Luca, Saul, Shira Rebecca, Copperman, Alan B., Hammerstad, Sara Salehi, Yi, Zhengzi, Zhang, Weijia, Tomer, Yaron, Kase, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741701/ https://www.ncbi.nlm.nih.gov/pubmed/29326659 http://dx.doi.org/10.3389/fendo.2017.00352 |
Ejemplares similares
-
Diabetes and Hepatitis C: A Two-Way Association
por: Hammerstad, Sara Salehi, et al.
Publicado: (2015) -
The pregnancy outcomes of infertile women with polycystic ovary syndrome undergoing intrauterine insemination with different attempts of previous ovulation induction
por: Gao, Yining, et al.
Publicado: (2022) -
Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019) -
The role of the thyroid in polycystic ovary syndrome
por: Fan, Huanhuan, et al.
Publicado: (2023) -
Editorial: Epigenetics of polycystic ovary syndrome
por: Parker, Jim, et al.
Publicado: (2023)